Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.
GV20 Therapeutics
1 follower
Bristol-Myers Squibb
320 followers
Deep Forest Sciences
1 follower
Viatris
54 followers
NYU Langone Health
51 followers
Alnylam Pharmaceuticals
50 followers
Syneos Health
38 followers
Catalent
36 followers
Parexel
21 followers
Charlie Health
15 followers
West Pharmaceutical Services
12 followers
Madrigal Pharmaceuticals
10 followers